bibliographic entry 877682 [be/877682]
https://w3id.org/oc/corpus/be/877682

is a

• bibliographic reference

content

• Robert, C, Ribas, A, Wolchok, JD, Hodi, FS, Hamid, O, Kefford, R. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomized dose-comparison cohort of a phase 1 trial, Lancet, 2014, 384, 1109, 1117, PMID: 25034862

references

• https://w3id.org/oc/corpus/br/42134